Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Sander

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Frontiers in Medicine|February 27, 2023
Determinants of patient and physician global assessments of disease activity in anti-neutrophil cytoplasmic antibody-associated vasculitisMarius Rohde, Anna Kernder, Hasan Acar, et al.
Antiviral Therapy|November 21, 2007
Predicting HIV coreceptor usage on the basis of genetic and clinical covariatesTobias Sing, Andrew J Low, Niko Beerenwinkel, et al.
Malaria Journal|August 2, 2011
Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysisSteven E Kern, Alfred B Tiono, Michael Makanga, et al.
Advances in Rheumatology (London, England)|January 5, 2022
Musculoskeletal ultrasound as a screening-tool for rheumatoid arthritis: results of the "Rheuma-Truck" screening and awareness initiativeAlexander Lautwein, Benedikt Ostendorf, Stefan Vordenbäumen, et al.
The Journal of Rheumatology|November 5, 2002
A single dose, placebo controlled study of the fully human anti-tumor necrosis factor-alpha antibody adalimumab (D2E7) in patients with rheumatoid arthritisAlfons den Broeder, Leo van de Putte, Rolf Rau, et al.
Journal of Patient-Reported Outcomes|June 10, 2026
Evaluating disease burden in German AAV patients using the AAV-PRO: associations with disease activity, physical function, depression, fatigue and quality of lifeMiriam Jacobs, Tim Filla, Gamal Chehab, et al.
Clinical and Experimental Rheumatology|March 11, 2026
Validation of the German version of the ANCA-associated vasculitis patient-reported outcome questionnaireAmelie Niesmann, Miriam Jacobs, Tim Filla, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 23, 2023
On the climate emergency and the health of our patients: comment on the article by Dellaripa et alToni Hospach, Alexandre Belot, Michael W Beresford, et al.
Journal of Clinical Medicine|March 29, 2023
Proof-of-Concept Double-Blind Placebo-Controlled Trial Measuring Cartilage Composition in Early Rheumatoid Arthritis under TNF-α-Inhibitor TherapyMiriam Frenken, Benedikt Ostendorf, Ralph Brinks, et al.
Pneumologie (Stuttgart, Germany)|February 26, 2024
[Therapeutic Pathways in Sarcoidosis. A Position Paper of the German Society of Respiratory Medicine (DGP)]Dirk Skowasch, Francesco Bonella, Katharina Buschulte, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Frontiers in Medicine|February 27, 2023
Determinants of patient and physician global assessments of disease activity in anti-neutrophil cytoplasmic antibody-associated vasculitisMarius Rohde, Anna Kernder, Hasan Acar, et al.
Antiviral Therapy|November 21, 2007
Predicting HIV coreceptor usage on the basis of genetic and clinical covariatesTobias Sing, Andrew J Low, Niko Beerenwinkel, et al.
Malaria Journal|August 2, 2011
Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysisSteven E Kern, Alfred B Tiono, Michael Makanga, et al.
Advances in Rheumatology (London, England)|January 5, 2022
Musculoskeletal ultrasound as a screening-tool for rheumatoid arthritis: results of the "Rheuma-Truck" screening and awareness initiativeAlexander Lautwein, Benedikt Ostendorf, Stefan Vordenbäumen, et al.
The Journal of Rheumatology|November 5, 2002
A single dose, placebo controlled study of the fully human anti-tumor necrosis factor-alpha antibody adalimumab (D2E7) in patients with rheumatoid arthritisAlfons den Broeder, Leo van de Putte, Rolf Rau, et al.
Journal of Patient-Reported Outcomes|June 10, 2026
Evaluating disease burden in German AAV patients using the AAV-PRO: associations with disease activity, physical function, depression, fatigue and quality of lifeMiriam Jacobs, Tim Filla, Gamal Chehab, et al.
Clinical and Experimental Rheumatology|March 11, 2026
Validation of the German version of the ANCA-associated vasculitis patient-reported outcome questionnaireAmelie Niesmann, Miriam Jacobs, Tim Filla, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 23, 2023
On the climate emergency and the health of our patients: comment on the article by Dellaripa et alToni Hospach, Alexandre Belot, Michael W Beresford, et al.
Journal of Clinical Medicine|March 29, 2023
Proof-of-Concept Double-Blind Placebo-Controlled Trial Measuring Cartilage Composition in Early Rheumatoid Arthritis under TNF-α-Inhibitor TherapyMiriam Frenken, Benedikt Ostendorf, Ralph Brinks, et al.
Pneumologie (Stuttgart, Germany)|February 26, 2024
[Therapeutic Pathways in Sarcoidosis. A Position Paper of the German Society of Respiratory Medicine (DGP)]Dirk Skowasch, Francesco Bonella, Katharina Buschulte, et al.
Pageof 7